BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30881922)

  • 1. Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability.
    Yang F; Wu L; Xu W; Liu Y; Zhen L; Ning G; Song J; Jiao Q; Zheng Y; Chen T; Xie C; Peng L
    Front Cell Infect Microbiol; 2019; 9():18. PubMed ID: 30881922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
    Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of S267F variant of NTCP on the patients with chronic hepatitis B.
    Lee HW; Park HJ; Jin B; Dezhbord M; Kim DY; Han KH; Ryu WS; Kim S; Ahn SH
    Sci Rep; 2017 Dec; 7(1):17634. PubMed ID: 29247233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population.
    Casillas R; Tabernero D; Gregori J; Belmonte I; Cortese MF; González C; Riveiro-Barciela M; López RM; Quer J; Esteban R; Buti M; Rodríguez-Frías F
    World J Gastroenterol; 2018 Feb; 24(6):680-692. PubMed ID: 29456407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.
    Peng L; Zhao Q; Li Q; Li M; Li C; Xu T; Jing X; Zhu X; Wang Y; Li F; Liu R; Zhong C; Pan Q; Zeng B; Liao Q; Hu B; Hu ZX; Huang YS; Sham P; Liu J; Xu S; Wang J; Gao ZL; Wang Y
    Hepatology; 2015 Apr; 61(4):1251-60. PubMed ID: 25418280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status.
    Ezzikouri S; Chihab H; Elhabazi A; Wakrim L; Benjelloun S
    BMC Infect Dis; 2017 Jan; 17(1):99. PubMed ID: 28125961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Treeprasertsuk S; Tanwandee T; Charatcharoenwitthaya P; Thongsawat S; Leerapun A; Piratvisuth T; Boonsirichan R; Bunchorntavakul C; Pattanasirigool C; Pornthisarn B; Tuntipanichteerakul S; Sripariwuth E; Jeamsripong W; Sanpajit T; Poovorawan Y; Komolmit P
    Antivir Ther; 2018; 23(1):67-75. PubMed ID: 28635613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.
    Chuaypen N; Tuyapala N; Pinjaroen N; Payungporn S; Tangkijvanich P
    BMC Med Genet; 2019 May; 20(1):87. PubMed ID: 31117968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic variant of the NTCP gene is associated with HBV infection status in a Chinese population.
    Yang J; Yang Y; Xia M; Wang L; Zhou W; Yang Y; Jiang Y; Wang H; Qian J; Jin L; Wang X
    BMC Cancer; 2016 Mar; 16():211. PubMed ID: 26968990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases.
    Binh MT; Hoan NX; Van Tong H; Sy BT; Trung NT; Bock CT; Toan NL; Song LH; Bang MH; Meyer CG; Kremsner PG; Velavan TP
    Int J Infect Dis; 2019 Mar; 80():147-152. PubMed ID: 30685591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.
    Xu ZM; Gnouamozi GE; Rüeger S; Shea PR; Buti M; Chan HL; Marcellin P; Lawless D; Naret O; Zeller M; Schneuing A; Scheck A; Junier T; Moradpour D; Podlaha O; Suri V; Gaggar A; Subramanian M; Correia B; Gfeller D; Urban S; Fellay J
    Am J Hum Genet; 2024 Jun; 111(6):1018-1034. PubMed ID: 38749427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
    El-Mowafy M; Elgaml A; El-Mesery M; Elegezy M
    J Med Virol; 2017 Sep; 89(9):1559-1566. PubMed ID: 28390175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
    Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
    Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis.
    He C; He HY; Sun CF; Ojha SC; Wang H; Deng CL; Sheng YJ
    Am J Med Sci; 2022 Aug; 364(2):207-219. PubMed ID: 35398032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
    Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
    J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in sodium taurocholate cotransporting polypeptide are not associated with hepatitis B virus clearance in Chinese Tibetans and Uygurs.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Zhao M; Ba Z; Zhang Z; Wang L
    Infect Genet Evol; 2016 Jul; 41():128-134. PubMed ID: 27051045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.